Most embryonic stem cells are derived from embryos that develop from eggs that have been fertilized invitro—in a clinic—and then donated for research purposes. To obtain embryonic stem cells, the early embryo has to be destroyed. This means destroying a human life. A human embryo is a human being in the embryonic stage, just as an infant is a human being in the infant stage. No medical cures have resulted in working with embryonic stem cells.
Adult stem cells (also referred to as “non-embryonic” stem cells) are present in adults, children, infants, placentas, umbilical cords, and cadavers. Obtaining stem cells from these sources does not result in certain harm to a human being. In contrast to research on embryonic stem cells, adult stem cell research has already resulted in numerous instances of actual clinical benefit to patients.
Another potential obstacle encountered by researchers engaging in embryonic stem cell research is the possibility that embryonic stem cells would not be immunologically compatible with patients and would therefore be “rejected,” much like a non-compatible kidney would be rejected. A proposed solution to this problem is to create an embryonic clone of a patient and subsequently destroy the clone in order to harvest his or her stem cells. Cloning for this purpose has been termed “therapeutic” cloning—despite the fact that the subject of the research—the clone—is not healed but killed. No one should be free to pursue gain (financial, health-related, or otherwise) through immoral or unethical means such as the taking of innocent life. We must not sacrifice one class of human beings (the embryonic) to benefit another (those suffering from serious illness).
Click on the title of the articles below to view a printable copy:
Want to stay informed? Sign up to receive our action alerts and e-mails by CLICKING HERE.